secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2024-07-22T23:59:59+00:00
Accession:  0000950170-24-085057
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics launches rights offering of up to $10.3M in Units at $1.21/unit
--------------------------------------------------------------------------------

- Maximum 8,503,800 Units offered at $1.21/unit; each Unit includes one ordinary share, a 0.5-share 1-year warrant, and a 1-share 5-year warrant.
- Subscription period July 22 to August 6, 2024; rights are non-transferable; proceeds if fully subscribed ~$10.3M.
- Record date July 16, 2024; each shareholder/warrant holder receives one right per share/warrant to purchase 0.5 Units.
- One eligible warrant holder waived participation; Maxim Group LLC is dealer-manager.
- Rights offering previously disclosed; registration statement declared effective by SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024085057/0000950170-24-085057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024085057/itrm-20240722.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-085057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer